Keloid, which is an overgrowth of scar tissue around a wound, is common in people who are darker in complexion. Read on for details on Keloid and the role played by injections in treating keloid.
Though the exact cause of keloid is not known, it can develop after acne, body spots, piercings, lacerations, burns and other surgical wounds. Infection aggravates the risk of keloids. Fibroblasts (cells) are considered to be responsible for the production of keloids. Genetic factors, hormones and problems with the immune system can also lead to keloids.
Keloids are common in people with darker skins, especially Africans. The peak age for developing Keloids can be 10-30 years old, and are not common in the young and older demographics.
Keloids can sport a shiny appearance and appear in pink or red colours. Keloids, in some cases, can be large and unsightly. These scars can be itchy, tender or painful to the touch.
Hypertrophic scars are confined to the margins of the wound whereas keloids can develop after the injury and spread themselves beyond the injured area. While hypertrophic scarring is not caused by race or heredity, keloids may be caused by race and familial preponderance.
Hypertrophic scars may be treated with simple excision. Injections can also be considered. As with any procedure or treatment, results can vary by individual.
Special acne injections can be used to reduce large active painful cystic acne. Active acne can resolve within 1 to 2 days or longer. We recommend to have the injection as early as possible before larger cystic acne form.